IP Library Granted Patent US 9,629,832
Granted Patent B2
US 9,629,832 · App. 14/263,569 · Granted Apr 25, 2017

Physically and chemically stable nicotine-containing particulate material

Inventors: Henri Hansson (Helsingborg, SE); Arne Kristensen (Helsingborg, SE)
Assignee: Niconovum USA, Inc.
A61K31/4439A61K9/0058A61K9/146A61K9/1617A61K9/1652A61K31/465
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,629,832
App. No.
14/263,569
Granted
Apr 25, 2017
Kind
B2
Abstract

A nicotine-containing particulate material for release of nicotine, the material comprising a combination of nicotine or a pharmaceutically acceptable salt, complex or solvate thereof and a microcrystalline cellulose, The particulate material is stable upon storage and releases nicotine relatively fast. The particulate material can be used in the manufacture of nicotine-containing pharmaceutical composition, wherein the release of nicotine can be designed to be relatively fast so as to obtain a fast onset of action.

Claims (16)

1. A method for preparing a nicotine-containing particulate material comprising combining a crystalline cellulose with nicotine or a pharmaceutically acceptable salt, complex, or solvate thereof dissolved in a hydrophilic solvent comprising an alcohol or a combination thereof with water such that the nicotine is at least partially retained inside voids of the crystalline cellulose, wherein the nicotine or a pharmaceutically acceptable salt, complex, or solvate thereof is dissolved in the hydrophilic solvent before combining with the crystalline cellulose, and wherein the crystalline cellulose comprises particles with a mean size range of about 15 to about 250 μm.

2. The method according to claim 1 , wherein the crystalline cellulose comprises microcrystalline cellulose (MCC).

3. The method according to claim 1 , wherein the nicotine is sorbed in pores present in the crystalline cellulose.

4. The method according to claim 1 , wherein the hydrophilic solvent comprises ethanol.

5. The method according to claim 1 , wherein the prepared nicotine-containing particulate material comprises nicotine or a pharmaceutically acceptable salt, complex, or solvate thereof at a concentration of at the most about 20% w/w, said concentration being calculated as the nicotine base.

6. The method according to claim 5 , wherein the prepared nicotine-containing particulate material comprises nicotine or a pharmaceutically acceptable salt, complex, or solvate thereof at a concentration of at the most about 7.5% w/w, said concentration being calculated as the nicotine base.

7. The method according to claim 1 , wherein combining comprises mixing in a high shear mixer.

8. The method according to claim 1 , comprising drying the combined crystalline cellulose and nicotine or a pharmaceutically acceptable salt, complex, or solvate thereof.

9. The method according to claim 8 , wherein after drying, the prepared nicotine-containing particulate material is stable for at least 14 weeks when stored openly at 40° C. and 50% relative humidity.

10. The method according to claim 1 , comprising coating at least a portion of the nicotine-containing particulate material.

11. The method according to claim 1 , wherein the prepared nicotine-containing particulate material, when tested in an in vitro dissolution test, releases at least 90% w/w of the nicotine or the pharmaceutically acceptable salt, complex or solvate thereof within, at the most, about 30 minutes.

12. A method for preparing a nicotine-containing particulate material comprising:

dissolving nicotine or a pharmaceutically acceptable salt, complex, or solvate thereof in a hydrophilic solvent comprising an alcohol or a combination thereof with water;

combining the resultant solution with microcrystalline cellulose (MCC) in a high shear mixer, the MCC comprising particles with a mean size range of about 15 to about 250 μm; and

drying the combination to form MCC particles having nicotine or a pharmaceutically acceptable salt, complex, or solvate thereof at a concentration of at the most about 7.5% w/w, said concentration being calculated as the nicotine base, at least partially retained inside voids of the MCC;

wherein the dried combination is stable for at least 14 weeks when stored openly at 40° C. and 50% relative humidity.

Assignments (2)
CHANGE OF NAME Recorded May 19, 2020
From: NICONOVUM USA, INC.
To: MODORAL BRANDS INC.
Reel/Frame 052698/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: NICONOVUM AB
To: NICONOVUM USA, INC.
Reel/Frame 037813/0678 →
Continuity (3)
Continuation 10742580 · Dec 19, 2003
Provisional Application 60514050 · Oct 24, 2003
Related Publication 20140234392A1 · Aug 21, 2014